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History
A 2-year-old 22.3-kg (49.1-lb) neutered male Eng-
lish Springer Spaniel was referred for surgical treat-
ment of a left elbow joint fracture. The owner report-
ed an acute onset of non–weight-bearing lameness in 
the left forelimb with no history of trauma. Swelling 
in the region of the left elbow joint was seen on phys-
ical examination. A lateral condylar fracture of the 
left humerus was evident on radiographs provided by 
the referring veterinarian.
Open reduction and internal fixation of the con-
dylar fracture was scheduled for the day after admis-
sion. Results of the preanesthetic assessment were 
otherwise normal; therefore, the patient was classi-
fied as American Society of Anesthesiologists physi-
cal status II (mild systemic disease). The anesthesia 
protocol consisted of premedication with metha-
done (0.2 mg/kg [0.09 mg/lb], IV) in combination 
with acepromazine (0.01 mg/kg [0.0045 mg/lb], IV). 
Meloxicam (0.2 mg/kg, IV) was added for its anti- 
inflammatory effects as part of a multimodal analge-
sia protocol. General anesthesia was induced with 
propofol (2 mg/kg [0.9 mg/lb]) administered IV to 
effect (total dose, 44.6 mg). The patient was orotra-
cheally intubated, and anesthesia was maintained 
with isoflurane in oxygen administered via a circle 
breathing system. Monitoringa included an ECG and 
measurement of oxygen saturation by means of pulse 
oximetry, end-tidal partial pressure of CO2, end-tidal 
isoflurane concentration, and blood pressure (mea-
sured noninvasively with an oscillometric method). 
End-tidal isoflurane concentration was maintained at 
1.3% throughout surgery. Baseline cardiorespiratory 
parameters included heart rate of 100 beats/min, re-
spiratory rate of 12 breaths/min, and systolic, mean, 
and diastolic blood pressures of 110, 68, and 51 mm Hg, 
respectively. With the patient anesthetized, repeated 
radiography confirmed a fracture of the left lateral 
humeral condyle and incomplete ossification of the 
humeral condyle, consistent with the lack of a history 
of trauma.
An ultrasound-guided brachial plexus block was 
performed for intraoperative analgesia. The patient 
was positioned in right lateral recumbency for clip-
ping and standard aseptic preparation of the lateral 
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aspect of the left neck and shoulder area. Ultrasono-
graphic identification of the brachial plexus was per-
formed as previously described by Guilherme and 
Benigni.1 Briefly, the ultrasound transducer was po-
sitioned in a parasagittal plane, parallel to the long 
axis of the first rib. The left axillary artery and vein 
were identified in the transverse plane, and the con-
tributing nerves of the left brachial plexus (C6, C7, 
C8, and T1) were identified as circular hypoechoic 
structures dorsal to the axillary vessels. By means of 
a combination of the frequency selected and a sharp-
ening algorithm, ultrasonography revealed a mildly 
hyperechoic interface at the most superficial aspect 
of the nerves. A 22-gauge, 7-inch spinal needle was 
inserted with ultrasound guidance, and ropivacaineb 
(1 mg/kg [0.45 mg/lb] diluted with sterile water to 
provide a total injection volume of 5 mL of a 0.45% 
solution) was injected.
On completion of the brachial plexus block and af-
ter standard surgical preparation of the site, the patient 
was moved to the operating room for surgery. One hour 
after the start of surgery, the patient began to respond 
to surgical stimuli (heart rate, 140 beats/min; respira-
tory rate, 19 breaths/min; and systolic, mean, and dia-
stolic blood pressures, 140, 88, and 65 mm Hg, respec-
tively) in a manner compatible with intraoperative no-
ciception. Therefore, it was assumed that the brachial 
plexus nerve block was providing only partial analgesia, 
and a constant rate infusion of ketamine (10 µg/kg/min 
[4.5 µg/lb/min]) was started. The patient also received 
2 bolus doses of methadone (0.1 mg/kg [0.045 mg/lb]) 1 
hour apart, administered by slow IV injection. Because 
of the suspected partial brachial plexus nerve block, an 
additional methadone bolus was administered IV at the 
completion of surgery.
A left brachial plexus catheter was placed at the 
completion of surgery in an attempt to maintain ad-
equate analgesia. The brachial plexus was again identi-
fied by means of ultrasonography. A stab skin incision 
was made with a No. 11 scalpel blade dorsal to the 
ultrasound transducer, and an 18-gauge, 8-cm Tuohy 
needle (1.30 X 88 mm; 18 gauge and 3.5 in) was ad-
vanced until the tip was evident on the ultrasound 
image adjacent to the nerve roots of the left brachial 
plexus (Figure 1). A 1 mg/kg dose of ropivacaine di-
luted to a total concentration of 0.22% (3 mL of ropi-
vacaine plus 7 mL of saline [0.9% NaCl] solution) was 
injected, producing a fluid pocket surrounding the left 
brachial plexus, immediately adjacent to the identified 
nerve roots. A 20-gauge, 100-cm-long epidural cath-
eterc was then advanced into the fluid pocket, and the 
Tuohy needle was withdrawn. With the same needle, a 
subcutaneous tunnel was created extending from the 
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catheter entrance site to the dorsal midline. The catheter 
was advanced through this tunnel and secured to the 
skin with butterfly tape and simple interrupted sutures.
The patient recovered from anesthesia without ap-
parent complications. Sensory and motor blockade were 
tested by applying the tips of blunt hemostatic forceps to 
the skin below the left elbow joint and applying gentle fin-
ger pressure on the surgical incision. Responses to these 
tests were negative, compared with responses for the 
contralateral limb. Postoperative analgesia was provided 
with 10 mL of 0.22% ropivacaine administered every 6 
hours via the indwelling brachial plexus catheter. Local 
anesthetic volume and concentration were calculated to 
achieve sensory blockade of all brachial plexus nerve 
roots.2 The dog was evaluated for signs of pain before 
each dose of ropivacaine with the short-form Glasgow 
Composite Measure Pain Scale (CMPS-SF)3 for dogs (a 
score of 0 represents no pain; a score of 24 represents un-
bearable pain). On the day of surgery, the patient’s CMPS-
SF score was 1 each time it was evaluated. The dog ap-
peared comfortable and, 2 hours after extubation, started 
to bear weight on the operated limb. Meloxicam admin-
istration (0.1 mg/kg, SC, q 24 h) was continued during 
the postoperative period. On the basis of the low (≤ 3) 
pain scores, periodic assessments of sensory and motor 
blockade, and the dog’s apparent comfort, postoperative 
rescue analgesia (ie, opioid administration) was not pro-
vided during the period of ropivacaine administration via 
the brachial plexus catheter.
Twenty-four hours after surgery, 
the patient developed signs of Horner 
syndrome (ptosis and miosis of the left 
eye); therefore, the volume of 0.22% 
ropivacaine administered every 6 hours 
was decreased from 10 to 7 mL. After 4 
hours, signs of Horner syndrome had 
resolved and did not recur. No other 
complications were noted.4
Thirty-six hours after surgery, dur-
ing a short walk with the dog out of 
its kennel, the brachial plexus catheter 
became dislodged and consequently 
was removed. The CMPS-SF score was 
assessed 4 and 8 hours after catheter 
removal and was 1. The dog then devel-
oped severe lameness (CMPS-SF score, 
5), and buprenorphine (0.02 mg/kg 
[0.009 mg/lb], IV, q 6 h) was added to 
the analgesic protocol. The patient re-
mained comfortable during the remain-
der of the postoperative hospitalization 
period and was discharged 3 days after 
surgery with a prescription for meloxi-
cam (0.1 mg/kg/d, PO) for 5 days. On 
follow-up examination 1 month after 
surgery, the patient had improved clini-
cally. Follow-up radiography of the left 
elbow showed evidence of fracture 
healing.
Question
Can intermittently administered locoregional an-
algesia alone provide adequate postoperative analge-
sia for small animal surgical patients? How can differ-
ential blockade (ie, analgesia without nerve paralysis) 
be achieved?
Answer
Local anesthetic agents such as ropivacaine pro-
vide analgesia through reversible blockade of the so-
dium channels in nerve membranes, preventing the 
conduction of action potentials and hence blocking 
the transmission of painful stimuli.5 However, the ef-
fects last for only a few hours. Therefore, to achieve 
analgesia during the postoperative period (typically 
several days), repeated or continuous local anesthetic 
administration close to the nerve is mandatory.6 In the 
patient of the present report, we placed a perineural 
catheter to facilitate repeated administration of ropi-
vacaine. The patient also received meloxicam (0.2 
mg/kg the first day and then 0.1 mg/kg, PO, q 24 h) 
perioperatively for its anti-inflammatory and analge-
sic effects as part of a multimodal analgesic protocol. 
Good-quality postoperative analgesia, as determined 
with the CMPS-SF for dogs, was achieved for 36 hours 
(until the catheter was inadvertently dislodged), and 
no opioid rescue analgesia was needed during that 
period. Moreover, we achieved subjectively good 
Figure 1—Ultrasonographic image of a 2-year-old neutered male English 
Springer Spaniel illustrating placement of a brachial plexus catheter for post-
operative locoregional analgesia after open reduction and internal fixation of 
a left humeral condyle fracture. The patient was anesthetized and positioned 
in right lateral recumbency; the ultrasound transducer was located in a para-
sagittal plane, parallel to the long axis of the first rib. After identification 
of the left brachial artery (circle) and the C6, C7, C8, and T1 nerve roots 
of the left brachial plexus (open arrows), a 20-gauge, 100-cm-long epidural 
catheterc (white arrows) was inserted via a subcutaneous tunnel and secured 
in place. 
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sensory blockade without complete paralysis of the 
affected limb. Local anesthetic type and concentra-
tion may influence which nerve fibers are blocked. 
Sensory blockade alone is achieved if the nerve fiber 
is exposed to a low concentration of local anesthetic, 
whereas a higher concentration can produce motor 
blockade.7 Ropivacaine and bupivacaine have been 
compared to evaluate which has superior differential 
blockade effects, but the results are equivocal.8,9
Discussion
Effective analgesia is essential for surgical pa-
tients during surgery and in the postoperative pe-
riod. Pain is well recognized as an important factor 
that can increase the incidence of surgical site infec-
tion and have other deleterious effects on recovery 
if not appropriately managed. Perineural catheters 
for peripheral nerve blocks are currently used in 
human patients to control postoperative pain.5 Re-
ported advantages include a decreased need for 
systemic analgesics (including opioids, which have 
been associated with adverse effects such as nausea 
and vomiting), highly effective analgesia facilitat-
ing early ambulation and introduction of physical 
therapy in the immediate postoperative period, and 
a relatively low incidence of complications.9 Periop-
erative pain management through administration of 
local anesthetics and anti-inflammatory drugs may 
prevent chronic pain and windup mechanisms (ie, 
increased sensitivity of spinal cord neurons result-
ing in increased pain sensation).10–12 The use of an 
indwelling catheter placed in the brachial plexus 
area has been described for continuous or repeat-
ed administration of local anesthetics to treat pain 
in dogs.13,14 In these case reports, the catheter was 
placed by means of a peripheral nerve stimulator 
to locate the appropriate position for the tip of the 
catheter. Additionally, 2 recent reports4,15 describe 
ultrasound-guided brachial plexus blocks in dogs. 
These studies did not evaluate ultrasound-guided 
catheter placement.
The canine brachial plexus is formed by the sixth, 
seventh, and eighth cervical spinal nerves and the first 
thoracic spinal nerve. Contributions can also arise 
from the ventral branch of the fifth cervical spinal 
nerve and the second thoracic spinal nerve.1 An effec-
tive nerve block is dependent on the precision of local 
anesthetic delivery to the target nerve root. Individual 
anatomic variations and operator experience make 
performing this local block challenging, leading to 
variable efficacy or partial blockade. Ultrasonographi-
cally, the brachial plexus can be identified in dogs by 
following the origin of the nerve roots from the neural 
foramina of the cervical vertebrae until formation of 
the brachial plexus cranial to the first rib.1 Other previ-
ously reported approaches for performing ultrasound-
guided brachial plexus blocks include the ventral axil-
lary15 and the paravertebral approach.4
A suggested advantage of the use of ultrasonog-
raphy versus nerve stimulation for location of the 
brachial plexus is the relatively easy identification of 
anatomic landmarks and visualization of the catheter 
as it is advanced into position, minimizing the risk of 
accidental vascular puncture and potential neurolog-
ic complications that may result from intraneural in-
jections. Another potential advantage in patients with 
trauma such as fractures is that pain during catheter 
placement is minimized, avoiding movements evoked 
by application of the peripheral nerve stimulator to 
an injured limb. Malher and Reece14 did not report 
signs of discomfort during use of electrostimulation 
in a dog with open fractures; however, analgesia 
and sedation were provided by means of adminis-
tration of meperidine (7 mg/kg [3.2 mg/lb]) before 
the procedure. Disadvantages of ultrasound-guided 
techniques are the need for ultrasound equipment of 
sufficient quality to identify the detailed structures 
of the brachial plexus and the operator experience 
required. Currently, there are no studies available 
comparing the accuracy and success of the 2 tech-
niques described for brachial catheter placement in 
veterinary patients.
In the patient of the present report, we chose 
ropivacaine over other amide-based local anesthetics 
because it offers a relatively long duration of action8,9 
and fewer cardiotoxic effects, compared with other 
long-lasting local anesthetics such as bupivacaine.9,16 
The dose used for repeated administration (1 mg/kg, 
q 6 h) was calculated in an effort to minimize the risk 
of systemic toxicosis, and the drug was diluted to a 
low concentration (0.22%) in an effort to achieve sen-
sory blockade (myelinated fibers of afferent sensory 
type A δ fibers or unmyelinated sensory C fibers).11,12 
It became apparent intraoperatively that the volume 
injected before surgery was not sufficient to com-
pletely block the brachial plexus. For this reason, and 
on the basis of a previous study2 in which a minimum 
effective anesthetic volume of 0.3 mL/kg (0.14 mL/lb) 
was necessary to achieve complete brachial plexus 
block in dogs, the 1 mg/kg dose administered during 
the postoperative period was diluted to a concentra-
tion of 0.22% (3 mL of ropivacaine in 7 mL of saline 
solution). 
In the patient of the present report, we believe 
that the sensory block provided effective postopera-
tive analgesia as demonstrated both by consistently 
low pain scores and the lack of requirement for res-
cue opioid administration. Pain scales are semiquan-
titative measures of pain in veterinary patients and 
should be used with caution; however, the CMPS-SF 
has been previously validated for use in dogs.17 De-
gree of motor blockade was assessed with periodic 
assessment of conscious proprioception in the af-
fected limb and slow leash walking. No additional 
clinical interventions were required to prevent mo-
tor blockade.
Transient Horner syndrome developed during 
the postoperative period in the patient described in 
the present report. We suggest that in this dog, the 
injected volume of ropivacaine (10 mL) was sufficient 
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to diffuse to areas beyond the brachial plexus such 
as the stellate ganglion, producing the clinical signs 
(ptosis and miosis). In this patient, the clinical signs 
resolved after 4 hours, and a subsequent decrease in 
the volume of drug injected apparently prevented re-
currence. This transient adverse event was described 
previously as a complication of paravertebral plexus 
block in a dog,18 with resolution of clinical signs after 
drug absorption. 
In the patient of the present report, the brachial 
plexus catheter became dislodged after 36 hours. We 
suggest that creation of a longer subcutaneous tun-
nel may facilitate more secure suture fixation and de-
crease the risk of premature dislodgement with resul-
tant early termination of locoregional analgesia when 
placing brachial plexus catheters in dogs.
Footnotes
a. S/5 multiparametric monitor, GE Medical, Hatfield, Hertfordshire, 
England.
b. Naropin, AstraZeneca plc, London, England.
c. Espocan epidural catheter, B. Braun Medical Ltd, Sheffield, 
South Yorkshire, England.
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